Mental Health and Social Support Are Key Predictors of Resilience in German Women with Endometriosis during the COVID-19 Pandemic

Schwab, Roxana; Stewen, Kathrin; Kottmann, Tanja; Anić, Katharina; Schmidt, Mona Wanda; Elger, Tania; Theis, Susanne; Kalb, Stefanie Roxana; Brenner, Walburgis; Hasenburg, Annette

doi:10.3390/jcm11133684

Cited by 7 publications

(5 citation statements)

References 74 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For instance, a cross-sectional study of 408 young women reported menstrual pain in 84% of participants with more than half reporting the occurrence of pain during each period [4]. Thus, dysmenorrhea is one of the most common causes of pelvic pain and has an adverse impact on quality of life, work productivity, absenteeism, and health care utilization [1][2][3]5,6].…”

Section: Introductionmentioning

confidence: 99%

Real-World Effects of a Hyoscine Butylbromide plus Paracetamol Combination in Women with Dysmenorrhea: A Patient Survey

Stewen,

Miehle,

Weigmann

et al. 2024

Preprint

View full text Add to dashboard Cite

Dysmenorrhea symptoms are frequent and often self-treated using non-prescription medicines. To further characterize women with dysmenorrhea using a combination of hyoscine butylbromide and paracetamol (PLUS) for self-management of their complaints, we performed a secondary analysis of a published pharmacy-based patient survey. 314 women (mean age 32.3 years) with dysmenorrhea reported a pain and cramps intensity of 7.45 ± 2.13 on a 0-10 Likert scale, which was reduced to 2.86 ± 1.81 upon treatment. Associated impairments of work/daily chores, leisure activities, and sleep were improved by 64.6%, 62.2% and 70.4%, respectively. The onset of symptom relief was within 60 min in 84.7%. Tolerability was rated as very good or good by 97.2%. These findings confirm the efficacy and tolerability data on PLUS from randomized controlled trials in a larger group of women conducting self-management of their dysmenorrhea.

show abstract

Section: Introductionmentioning

confidence: 99%

Real-World Effects of a Hyoscine Butylbromide plus Paracetamol Combination in Women with Dysmenorrhea: A Patient Survey

Stewen,

Miehle,

Weigmann

et al. 2024

Preprint

View full text Add to dashboard Cite

show abstract

“…Of these, three published papers appear J.I. Spencer 1,2 , G. MezquIta 1 , F. ShakIr 1 to have analysed results from the same survey (Schwab et al,2021;Schwab et al, 2022a;Schwab et al,2022b). One mid-2020 case-control study in 1,027 patients in Iran showed no change in Covid-19 infection in endometriosis patients (Moazzami et al, 2021), whilst another smaller case-control study of 401 patients in Italy conducted between March 2020 and April 2021 showed a slight increase in number of infections in endometriosis patients (Barretta et al, 2022).…”

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

“…There are only 14 published studies examining the effects of Covid-19 on endometriosis patients ( Arena et al, 2021 ; Armour et al, 2022 ; Ashkenazi et al, 2022 ; Barretta et al, 2022 ; Demetriou et al, 2021 ; Evans et al, 2021 ; Moazzami et al, 2021 ; Nicolás et al, 2022 ; Rosielle et al, 2021 ; Schwab et al, 2021 ; Schwab et al, 2022a ; Schwab et al, 2022b ; Uccella et al, 2021 ; Yalçın Bahat et al, 2020 ). Of these, three published papers appear to have analysed results from the same survey ( Schwab et al, 2021 ; Schwab et al, 2022a ; Schwab et al, 2022b ). One mid-2020 case-control study in 1,027 patients in Iran showed no change in Covid- 19 infection in endometriosis patients ( Moazzami et al, 2021 ), whilst another smaller case-control study of 401 patients in Italy conducted between March 2020 and April 2021 showed a slight increase in number of infections in endometriosis patients ( Barretta et al, 2022 ).…”

Section: Introductionmentioning

confidence: 99%

“…As the pandemic approaches its third year, it is increasingly important to understand endometriosis patients’ experiences to provide better support and allocate health resources. None of the above surveys ( Arena et al, 2021 ; Armour et al, 2022 ; Ashkenazi et al, 2022 ; Demetriou et al, 2021 ; Evans et al, 2021 ; Nicolás et al, 2022 ; Rosielle et al, 2021 ; Schwab et al, 2022a , 2022b , 2021 ; Uccella et al, 2021 ; Yalçın Bahat et al, 2020 ) include data beyond January 2021. We aimed to better understand the ongoing effects of Covid-19 on endometriosis patients, using an online survey sent in mid-2021.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

The ongoing impact of the Covid-19 pandemic on endometriosis patients: A survey of 1,089 UK patients

Spencer¹,

Mezquita²,

Shakir³

2022

Facts Views Vis ObGyn

View full text Add to dashboard Cite

Background: The impact of Covid-19 on endometriosis patients is under-researched. Endometriosis has significant psychosocial effects on patients. Moreover, the mainstay of diagnosis and treatment of endometriosis is elective surgery, impacted as a result of healthcare strain. Objective: To better understand the effect of the Covid-19 pandemic on endometriosis patients Materials and Methods: An online survey sent to adult UK endometriosis patients between 27th August and 15th September 2021. The study received HRA and HCRW research ethic committee approval. Main outcome measures: Effects of the Covid-19 pandemic on endometriosis symptoms and surgery Results: We received 1,089 survey responses. Respondents had a median age of 34, and 82.0% of respondents were white British. 18.8% of respondents reported a previous positive Covid-19 PCR test. 84.6% of patients had been double vaccinated at time of response. 20 patients reported Covid-related hospital admission, with 1 requiring intubation. Large numbers of patients (31.4-55.2%) reported worsening of endometriosis symptoms during the pandemic. 69.2% of respondents reported worsening of associated mental health symptoms. Whilst 44% of respondents had elective endometriosis surgery planned, the majority of operations were disrupted, and 18.7% of total respondents did not have a new surgery date. Conclusions: More research and support are needed for endometriosis patients as they wait longer for surgery. A holistic approach, encompassing mental health needs, may be particularly beneficial for patients. What is new? This is the first survey examining the effects of Covid-19 on endometriosis patients including data beyond January 2021.

show abstract

Predictors of anxiety in endometriosis patients

Kupec,

Wagels,

Caspers

et al. 2024

Arch Gynecol Obstet

View full text Add to dashboard Cite

Purpose To evaluate the main factors influencing anxiety in endometriosis patients presenting to an endometriosis centre in Germany. Methods One hundred and eighty-two patients were asked to complete the German version of the STAI (state anxiety and trait anxiety) questionnaire prior to examination for diagnosis and treatment of pelvic pain or suspected endometriosis. Typical endometriosis symptoms, main complaints, operations, type of endometriosis and planned treatment were analyzed as influencing factors of anxiety in endometriosis patients. We performed linear multiple regression analyses using the forward stepwise method to test which characteristics associated with endometriosis symptoms were associated with trait anxiety and state anxiety. Results Analysis of the STAI results showed that higher levels of trait anxiety were found in patients with ovarian endometriosis: t (177) = 3.06, p = 0.003 and in patients with symptoms of dyspareunia: t (177) = 2.36, p < 0.020). On the other hand, patients with recurrent endometriosis showed lower levels of trait anxiety: t (177) = − 2.39, p = 0.018. Significantly higher levels of state anxiety were found in patients with persistent endometriosis: t (177) = − 2.45, p = 0.015 and in women with endometriosis who were indicated for surgical therapy: t (177) = 3.89, p < 0.001. Conclusions We were able to show that higher levels of ongoing anxiety in endometriosis patients are associated with dyspareunia and ovarian endometriosis, which may have a negative impact on partnership and desire to have children. On the other hand, patients with persistent endometriosis or a type of disease that requires surgery have higher levels of immediate situational anxiety.

show abstract

Mental Health and Social Support Are Key Predictors of Resilience in German Women with Endometriosis during the COVID-19 Pandemic

Cited by 7 publications

References 74 publications

Real-World Effects of a Hyoscine Butylbromide plus Paracetamol Combination in Women with Dysmenorrhea: A Patient Survey

Real-World Effects of a Hyoscine Butylbromide plus Paracetamol Combination in Women with Dysmenorrhea: A Patient Survey

The ongoing impact of the Covid-19 pandemic on endometriosis patients: A survey of 1,089 UK patients

Predictors of anxiety in endometriosis patients

Contact Info

Product

Resources

About